CD34 and acute myeloid leukemia: When treating AML cell lines in combination with PRI-724, and chemotherapy sorafenib, the combination synergistically induced apoptosis AML cell lines, AML blasts, and FLT3-mutated CD34+CD38− AML stem/progenitor cells.